Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03375853
Other study ID # DK112762
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 15, 2017
Est. completion date September 15, 2023

Study information

Verified date September 2023
Source Oregon Research Institute
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This project will test whether a food response training intervention produces lasting body fat loss, use objective brain imaging to examine the mechanism of effect of this treatment and investigate the generalizability of the training to non-training foods, and examine factors that should amplify intervention effects to provide a test of the intervention theory. This novel treatment represents a bottom-up implicit training intervention that does not rely on executive control, prolonged caloric deprivation, and expensive clinicians to deliver, like behavioral weight loss treatments that have not produced lasting weight loss. If this computer-based response training intervention produces sustained body fat loss in overweight individuals, it could be easily implemented very broadly at almost no expense, addressing a leading public health problem.


Description:

Obesity causes 300,000 US deaths yearly, but most treatments do not result in lasting weight loss. People who show greater brain reward and attention region response, and less inhibitory region response, to high-calorie food images/cues show elevated future weight gain, consistent with the theory that overeating results from a strong approach response to high-calorie food cues paired with a weak inhibitory response. This implies that an intervention that reduces reward and attention region response to such food and increases inhibitory control region response should reduce overeating that is rooted in exposure to pervasive food cues. Computer-based response-inhibition training with high-calorie foods has decreased attentional bias for and intake of the training food, increased inhibitory control, and produced weight loss in overweight participants in 3 proof-of-concept trials, with effects persisting through 6-mo follow-up. A pilot trial found that overweight/obese adults who completed a multi-faceted 4-hr response-inhibition training with high-calorie food images and response-facilitation training with low-calorie food images showed reduced fMRI-assessed reward and attention region response to high-calorie training foods and greater body fat loss than controls who completed a rigorous 4-hr generic response-inhibition/response-facilitation training with non-food images (d=.95), producing a 7% reduction in excess body fat over the 4-wk period. The investigators propose to evaluate a refined and extended version of this response-training intervention. Aim 1: Randomize 180 overweight/obese adults to a 4-wk response training obesity treatment or a generic inhibition training control condition that both include bi-monthly Internet-delivered booster training for a year and a smart phone response training app that can be used when tempted by high-calorie foods, assessing outcomes at pre, post, and at 3-, 6-, and 12-month follow-ups (e.g., % body fat, the primary outcome). Aim 2: Use fMRI to test whether reduced reward and attention region response, and increased inhibitory region response to high-calorie food images used and not used in the response training mediate the effects of the intervention on fat loss. The investigators will also test whether during training participants show acute reductions in reward and attention region response, and increases in inhibitory response to high-calorie training food images to capture the learning process, assess generalizability of the intervention to food images not used in training, and collect behavioral data on mediators. Aim 3: Test whether intervention effects will be stronger for those who show less inhibitory control in response to high-calorie food images, a genetic propensity for greater dopamine signaling in reward circuitry, and greater pretest reward and attention region response, and weaker inhibitory region response to high-calorie food images, based on the theory that response training is more efficacious for those with a strong pre-potent approach tendency to high-calorie foods. During the Covid-19 shelter-at-home order, we will not measure in person only outcomes including BodPod assessments, height and weight measurement for BMI calculation, electrocardiogram (ECG) assessments and fMRI scanning for all participants that have assessments due during this order.


Recruitment information / eligibility

Status Completed
Enrollment 179
Est. completion date September 15, 2023
Est. primary completion date August 31, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 38 Years
Eligibility Inclusion Criteria: - Body Mass Index Between 25 and 35 Exclusion Criteria:

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Computer Based Response Training Weight Loss Intervention
Participants complete four computer based training tasks each visit, over the course of a few lab visits. Participants then perform weekly booster sessions in a more natural home or community environment over the internet using the same computer based training tasks.
Generic Response Training Control Intervention
Participants complete four computer based training tasks each visit, over the course of a few lab visits. Participants then perform weekly booster sessions in a more natural home or community environment over the internet using the same computer based training tasks.

Locations

Country Name City State
United States Oregon Research Institute Eugene Oregon

Sponsors (5)

Lead Sponsor Collaborator
Oregon Research Institute Flinders University, Radboud University Medical Center, University of Exeter, University of Oregon

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Body Fat Change Change in participant's body fat percentage Baseline, 1 month, 3 months, 6 months, 12 months
Secondary Change in Eating Disorder Symptoms Eating disorder symptoms as measured with the Eating Disorder Diagnostic Interview Baseline, 1 month, 3 months, 6 months, 12 months
Secondary Dietary Restraint, Emotional Eating, and External Eating Change in Dietary Restraint, Emotional Eating, and External Eating (aggregate score) as measured by the Dutch Eating Behavior Questionnaire Baseline, 1 month, 3 months, 6 months, 12 months
Secondary Change in Disinhibited Eating Behavior Chang in Disinhibited Eating as measured by the Three Factor Eating Questionnaire Baseline, 1 month, 3 months, 6 months, 12 months
Secondary Change in Eating in the Absence of Hunger Behavior Change in Eating When Not Hungry as measured by the Eating in the Absence of Hunger Questionnaire Baseline, 1 month, 3 months, 6 months, 12 months
Secondary Change in Food Addiction Behavior Change in Problematic eating patterns associated with symptoms of addictive behaviors as measured by the Yale Food Addiction Scale Baseline, 1 month, 3 months, 6 months, 12 months
Secondary Change in Physical Activity Change in Physical Activity as measured by the Paffenberger Questionnaire Baseline, 1 month, 3 months, 6 months, 12 months
Secondary Change in Alcohol Use Behavior Change in Substance use frequency (i.e., number of times per day) for alcohol of participants as measured by the Daily Drinking Questionnaire Baseline, 1 month, 3 months, 6 months, 12 months
Secondary Change in Substance Use Behavior Change in Substance use frequency (i.e., number of times per day) for common recreational drugs of participants as measured by the Daily Drug Taking Questionnaire Baseline, 1 month, 3 months, 6 months, 12 months
Secondary Change in Participant Ratings of Unhealthy Food Palatability Change in Participant behavioral response to food pictures, and subjective palatability rating Baseline, 1 month
Secondary Change in Participant Ratings of Food Monetary Value Change in Participant behavioral response to food pictures, and willingness to pay given dollar amounts (aggregate score) for the pictured food Baseline, 1 month
Secondary Change in Food Craving and Liking Behavior Change Participant food craving behaviors as measured by the Food Craving and Liking Scale Baseline, 1 month, 3 months, 6 months, 12 months
Secondary Change in Body Mass Index Change in Participant BMI using standard methods of calculation Baseline, 1 month, 3 months, 6 months, 12 months
Secondary Change in mean R-Peak Amplitude Change in mean R-Peak Amplitude measured using three-lead ECG using PowerLab 8 Diagnostic Suite Baseline, 1 month, 3 months, 6 months, 12 months
Secondary Change in Heart Rate Variability Change in Heart Rate Variability measured using three-lead ECG using PowerLab 8 Diagnostic Suite Baseline, 1 month, 3 months, 6 months, 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2